| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_45c0430dd45ca6c64640c228acd8a48c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-31 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-07049 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
2007-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2545f39cc53da56aa38c58096a14032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdd6e209e8ece48eec33b24ce4bf41cf |
| publicationDate |
2015-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2533264-T3 |
| titleOfInvention |
Telomerase and gemcitabine inhibitor combined for cancer treatment |
| abstract |
The use of a telomerase inhibitor in the preparation of a medicament to inhibit the proliferation of cancer cells in a subject that is being treated either sequentially or simultaneously with gemcitabine, where the telomerase inhibitor comprises an oligonucleotide characterized by: (i ) N3 '→ P5' thiophosphoramidate type nucleoside junctions; (ii) have the sequence identified as SEQ ID NO: 12 and (iii) a palmitoyl moiety (C16) attached to the 5 'end of the oligonucleotide via a glycerol or aminoglycerol type linker. |
| priorityDate |
2006-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |